A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Condition:   Chronic Hepatitis B Interventions:   Drug: HRS9950 tablets;   Drug: HRS9950 placebo tablets Sponsor:   Chengdu Suncadia Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials